Does CLORAZEPATE Cause Mobility decreased? 8 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Mobility decreased have been filed in association with CLORAZEPATE (Clorazepate Dipotassium). This represents 0.5% of all adverse event reports for CLORAZEPATE.
8
Reports of Mobility decreased with CLORAZEPATE
0.5%
of all CLORAZEPATE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Mobility decreased From CLORAZEPATE?
Of the 8 reports, 4 (50.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLORAZEPATE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CLORAZEPATE Cause?
Coma (203)
Toxicity to various agents (173)
Somnolence (142)
Off label use (109)
Drug abuse (98)
Hypotension (96)
Intentional overdose (94)
Drug ineffective (92)
Fall (92)
Anxiety (78)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CLORAZEPATE Alternatives Have Lower Mobility decreased Risk?
CLORAZEPATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLORAZEPATE vs CLOTHIAPINE
CLORAZEPATE vs CLOTIAZEPAM
CLORAZEPATE vs CLOTRIMAZOLE
CLORAZEPATE vs CLOXACILLIN